Health Care Without Harm

Health Care Without Harm
Name	Health Care Without Harm
Formation	1996
Type	Nonprofit organization
Headquarters	Boston, Massachusetts
Region served	Global
Focus	Environmental health, sustainable healthcare

Health Care Without Harm Health Care Without Harm is an international coalition of health care institutions and advocacy groups focused on reducing the environmental footprint of medical systems and protecting public health from hazardous chemicals and greenhouse gas emissions. Founded in 1996 amid rising attention to toxic waste and climate change, the organization collaborates with hospitals, ministries, multilateral agencies, and environmental networks to promote safer procurement, waste reduction, and low-carbon transitions. It works alongside partners in health policy, environmental regulation, and clinical practice to translate scientific evidence into institutional change.

History

Health Care Without Harm emerged in 1996 when leaders from Center for Health, Environment & Justice, Physicians for Social Responsibility, Friends of the Earth, United Nations Environment Programme, and World Health Organization-associated experts convened to address occupational and community exposures from hospitals. Early campaigns drew on precedents set by Clean Air Act litigation, Superfund remediation strategies, and the phaseout efforts that affected asbestos and DDT. The organization’s work in the late 1990s and early 2000s intersected with initiatives such as the Basel Convention on hazardous wastes, negotiations around the Stockholm Convention on persistent organic pollutants, and the transition away from mercury-containing medical devices. Over subsequent decades it expanded ties to institutions like World Bank, European Commission, Pan American Health Organization, and national health ministries to scale procurement policies, energy projects, and waste management reforms.

Mission and Goals

The organization’s mission emphasizes protecting patient and worker health by eliminating hazardous substances, reducing greenhouse gas emissions, and promoting sustainable health care delivery in line with frameworks such as the Paris Agreement and Sustainable Development Goals. Its stated goals include replacing toxic reagents and devices exemplified by historical debates over mercury and PVC, accelerating hospital energy resilience modeled after LEED and Green Building Council standards, and mainstreaming circular economy practices following principles discussed at World Economic Forum and Organisation for Economic Co-operation and Development. The goals aim to influence procurement within networks like National Health Service and Kaiser Permanente while informing regulators connected to agencies such as the Environmental Protection Agency and the European Medicines Agency.

Programs and Initiatives

Programs have targeted clinical and infrastructure change, including campaigns to eliminate mercury thermometers and phasing out desflurane and nitrous oxide in anesthesia suites in coordination with professional bodies like the American Medical Association and the Royal College of Physicians. Initiatives include green procurement platforms that engage suppliers comparable to contract reforms used by United Nations procurement, energy decarbonization projects partnering with development lenders like the World Bank and African Development Bank, and waste management pilots aligned with Basel Convention guidance and WHO health care waste policies. Other efforts involve training programs and toolkits for hospital leaders inspired by accreditation regimes such as Joint Commission standards and sustainability frameworks used by Global Green and Healthy Hospitals. The organization also publishes case studies and guides used by networks including Health Action International, Global Fund, GAVI, and national hospital associations.

Policy and Advocacy

Policy work leverages scientific reports, stakeholder engagement, and litigation-adjacent advocacy similar to campaigns by Greenpeace and Natural Resources Defense Council to influence laws, regulations, and procurement rules. Efforts have targeted policy instruments such as extended producer responsibility schemes reflected in European Union directives, national bans informed by the Minamata Convention on Mercury, and health sector emissions reporting paralleling commitments under UNFCCC processes. The group interacts with legislative bodies and ministries that implement statutes like chemical safety laws in countries led by ministers associated with institutions such as Department of Health and Human Services and Ministry of Health (United Kingdom), and it contributes to standards discussed in forums like Codex Alimentarius and International Organization for Standardization committees.

Partnerships and Global Impact

Partnerships include alliances with hospitals and health systems such as Massachusetts General Hospital, Guy's and St Thomas' NHS Foundation Trust, and regional networks like Latin American and Caribbean Network for Environmental Health. Collaborations extend to academic institutions including Harvard T.H. Chan School of Public Health, Johns Hopkins Bloomberg School of Public Health, and University of Cape Town for research and capacity-building. The organization has engaged multinational agencies including WHO, UNEP, World Bank, and philanthropic funders like Wellcome Trust and Rockefeller Foundation to scale interventions across continents, affecting procurement in systems such as National Health Service and influencing policy in countries represented at Conference of the Parties (UNFCCC). Its global programs have been cited in reports produced by Intergovernmental Panel on Climate Change and incorporated into resilience planning used by city authorities like New York City and Bangkok Metropolitan Administration.

Criticisms and Controversies

Critics have questioned the feasibility and cost-effectiveness of rapid transitions promoted by the organization, comparing debates to contentious reform efforts in large systems managed by entities like NHS England and Centers for Medicare & Medicaid Services. Some supplier and industry groups have contested procurement restrictions as resembling trade disputes adjudicated before bodies like the World Trade Organization and have raised concerns paralleling past controversies involving pharmaceutical and medical device supply chain regulation. Academic commentators have debated the balance between precautionary approaches and evidence thresholds used by advisory panels similar to those convened by National Academies of Sciences, Engineering, and Medicine. The organization has responded through partnership-driven pilots and peer-reviewed studies co-authored with researchers from institutions such as Imperial College London and McMaster University to address performance, cost, and equity considerations.

Category:Non-profit organizations